In silico drug discovery pipelines targeting antibiotic resistance: from genomes to leads.

Gupta R, Singh P, Ravi K, Abomughaid MM, Lakhanpal S, Sharma R, Kumar N, Jha NK

Open source

DOI
10.3389/fbinf.2026.1839606
Published
2026
Container
Frontiers in bioinformatics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fbinf.2026.1839606,
  title = {In silico drug discovery pipelines targeting antibiotic resistance: from genomes to leads.},
  author = {Gupta R and Singh P and Ravi K and Abomughaid MM and Lakhanpal S and Sharma R and Kumar N and Jha NK},
  year = {2026},
  journal = {Frontiers in bioinformatics},
  doi = {10.3389/fbinf.2026.1839606},
  url = {https://doi.org/10.3389/fbinf.2026.1839606}
}

RIS

TY  - JOUR
TI  - In silico drug discovery pipelines targeting antibiotic resistance: from genomes to leads.
AU  - Gupta R
AU  - Singh P
AU  - Ravi K
AU  - Abomughaid MM
AU  - Lakhanpal S
AU  - Sharma R
AU  - Kumar N
AU  - Jha NK
PY  - 2026
JO  - Frontiers in bioinformatics
DO  - 10.3389/fbinf.2026.1839606
UR  - https://doi.org/10.3389/fbinf.2026.1839606
ER  - 

APA

R, G., P, S., K, R., MM, A., S, L., R, S., N, K., & NK, J. (2026). In silico drug discovery pipelines targeting antibiotic resistance: from genomes to leads.. Frontiers in bioinformatics. https://doi.org/10.3389/fbinf.2026.1839606

Source records